HNB
SCPH

Huntington National Bank’s scPharmaceuticals SCPH Stock Holding History

Huntington National Bank’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-711
Closed -$1.87K – 4223
2025
Q1 		$1.87K Buy
+711
New +$2.32K ﹤0.01% 2243

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Huntington National Bank's SCPH Position: Q2 2025 in Review

Huntington National Bank sold out of scPharmaceuticals (SCPH) in Q2 2025, closing a stake of 711 shares — an estimated $1.87K sold.

Huntington National Bank first reported a position in SCPH in Q1 2025 and held it in 1 quarter. The position peaked at $1.87K in Q1 2025. 97 funds tracked by Wall St. Rank hold SCPH as of Q2 2025.

  • Huntington National Bank reported no remaining scPharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Huntington National Bank sold 711 scPharmaceuticals shares in Q2 2025, an estimated $1.87K.
  • Huntington National Bank first reported a position in scPharmaceuticals in Q1 2025 and held it in 1 quarter.
  • Huntington National Bank's scPharmaceuticals position peaked at $1.87K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2025.

Based on Huntington National Bank's 13F filing for Q2 2025, filed 5 Aug 2025.